" class="no-js "lang="en-US"> Piers Ingram - Medtech Alert
Sunday, February 05, 2023
Piers Ingram

Piers Ingram

About Piers Ingram

Related Story

Hummingbird Bioscience to Collaborate with Merck on Clinical Trial of Anti-VISTA Antibody HMBD-002 in Combination with KEYTRUDA® (Pembrolizumab) for Treatment of Cancer

October 25 2021

Hummingbird Bioscience, an innovative clinical-stage biotech company focused on developing precision therapies against hard-to-drug targets […]

Hummingbird Bioscience Strengthens Leadership Team with Appointment of Josh House as Chief Financial Officer

September 1 2021

Hummingbird Bioscience, an innovative clinical-stage biotech company focused on developing precision therapies against hard-to-drug targets, […]

Hummingbird Bioscience Appoints Renowned Scientist and Medical Oncologist Dr. Thomas J. Lynch to its Board of Directors

July 26 2021

Hummingbird Bioscience, an innovative clinical-stage biotech company focused on developing precision therapies against hard-to-drug targets, […]